Case Studies

Infusion pumps deliver medications at programmed rates or intervals. However, incorrect doses can occur if fluids are delivered at inaccurate flow rates, particularly drugs with narrow therapeutic margins, short half-life, high concentration, or the very low flow rates typical for newborn children. Therefore, accurate and prec...

Europe’s health services face demands for breakthrough cancer therapies assured as safe, personalised, and able to cost-effectively treat patients. In 2020, 2.7 million people in the European Union received a cancer diagnosis. About half underwent radiotherapy, including during diagnosis. Image-guided radiation therapies becam...

Should cancer incidence rates rise as predicted, Europe’s health services will face escalating demands for investment in advanced therapies assured as safe, personalised, and cost-effective. In 2020, 2.7 million people in the European Union received a cancer diagnosis. About half underwent radiotherapy, including during diagno...

Resistance to antibiotic treatments are responsible for approximately 33,000 deaths a year in Europe and infectious diseases were the leading cause of death among children under five. This includes bacteria that have developed resistance to Carbapenems, considered drugs of ‘last resort’ for Antimicrobial Resistance (AMR) infect...

In 2020, 2.7 million people in the European Union were diagnosed with cancer and 1.3 million lives were lost to the disease. The EU Commission supports research to improve prevention, detection, diagnosis and treatment of cancer. Quality of life for patients during treatment is also a priority, and is an important factor for ev...

Infusion pumps, also known as syringe pumps, are used to automatically deliver critical fluids to patients at precisely programmed rates or intervals. When these devices are used to administer high-risk medications, inaccuracies in delivered flow rates can have significant safety implications; especially for drugs with narrow ...